Medical-Grade Polyethylene Terephthalate Glycol (PETG) Market latest Statistics on Market Size, Growth, Production, Sales Volume, Sales Price, Market Share and Import vs Export 

Medical-Grade Polyethylene Terephthalate Glycol (PETG) Market Summary Highlights

The global Medical-Grade Polyethylene Terephthalate Glycol (PETG) Market is estimated at approximately USD 1.48 billion in 2026, supported by sustained demand from diagnostic packaging, pharmaceutical containers, surgical trays, respiratory components, and transparent medical housings. Material preference is shifting toward copolyester-based polymers that combine clarity, impact resistance, sterilization compatibility, and easier thermoforming compared to conventional acrylics and polycarbonate grades. Production investments across Asia-Pacific and North America are also influencing pricing stability and regional supply security for medical converters.

Healthcare packaging remains the largest application segment, accounting for more than one-third of total PETG consumption in medical environments in 2026. Increased outsourcing of medical device manufacturing, rising single-use medical component demand, and stricter compliance requirements for biocompatibility are strengthening procurement volumes across regulated healthcare supply chains. At the same time, resin producers are focusing on BPA-free positioning, recyclable copolyester solutions, and low-extractable formulations to secure contracts with pharmaceutical and diagnostic manufacturers.

Statistical Highlights – 2026 Snapshot

• Global market valuation for medical-grade PETG is projected at USD 1.48 billion in 2026
• Forecast market expansion estimated at 6.9% CAGR between 2026 and 2031
• Healthcare packaging contributes nearly 36% of total demand volume
• Asia-Pacific accounts for approximately 41% of global consumption in 2026
• Diagnostic and laboratory consumables segment expected to grow by 7.8% in 2026
• Thermoformed medical trays represent over 28% of application share
• BPA-free medical polymer demand has increased by nearly 11% year-over-year among device OEMs
• More than 54% of new hospital procurement specifications in developed markets now include recyclable or sustainability-linked polymer criteria
• Sterilization-compatible PETG formulations account for roughly 62% of commercial medical PETG grades
• North American medical device production spending is estimated to rise by 5.6% in 2026, supporting polymer demand
• Pharmaceutical blister and rigid transparent packaging applications are projected to exceed USD 420 million in material demand by 2026
• Recycled-content medical copolyester development projects increased by nearly 18% globally during 2025–2026

In February 2026, Eastman Chemical Company expanded specialty copolyester production planning for healthcare applications in response to rising demand from diagnostic packaging and medical device converters in North America. The company highlighted increased procurement from pharmaceutical packaging manufacturers seeking BPA-free transparent polymers.

In October 2025, SK Chemicals announced additional investment into sustainable copolyester material lines, including healthcare-focused grades intended for reusable and recyclable medical applications. The expansion reflected growing procurement activity from Asia-based medical packaging manufacturers.

In January 2026, the U.S. Food and Drug Administration issued updated guidance discussions around material traceability and extractable-risk assessments for medical packaging systems, increasing focus on validated medical polymer sourcing and documentation requirements.

In March 2026, DuPont expanded healthcare material partnerships for diagnostic device production in Europe, reflecting broader investment activity in high-clarity medical polymers used in laboratory consumables and imaging-related applications.

Expansion of Transparent Medical Packaging Applications

Demand growth in the Medical-Grade Polyethylene Terephthalate Glycol (PETG) Market continues to be heavily connected to rigid transparent healthcare packaging applications. Pharmaceutical companies and medical device assemblers increasingly prefer high-clarity copolyester materials because visibility requirements in sterile packaging environments have become more stringent across regulated healthcare systems.

Medical tray manufacturers are expanding PETG utilization in thermoformed packaging because of its dimensional stability and lower processing complexity compared with polycarbonate alternatives. In 2026, thermoformed sterile barrier systems represent one of the fastest-growing medical packaging segments, particularly in surgical kit packaging and catheter tray applications.

Hospital procurement standards are also affecting polymer selection patterns. Healthcare systems in Germany, Japan, and the United States have increased adoption of transparent packaging formats that support rapid visual inspection during storage and emergency use scenarios. This trend has supported rising demand for medical copolyesters with anti-stress whitening characteristics and gamma sterilization compatibility.

The healthcare packaging sector is additionally benefiting from pharmaceutical production expansion. In January 2026, European Federation of Pharmaceutical Industries and Associations reported continued growth in biologics manufacturing infrastructure across Europe, contributing to higher consumption of sterile packaging materials and laboratory handling products.

Single-Use Medical Devices Continue to Support Resin Consumption

The shift toward disposable medical components remains a major contributor to volume expansion within the Medical-Grade Polyethylene Terephthalate Glycol (PETG) Market. Single-use systems are increasingly preferred in respiratory therapy, fluid management, diagnostics, and infection-control applications due to contamination reduction requirements.

Healthcare providers continue prioritizing disposable product categories after sustained increases in hospital-acquired infection monitoring programs. Medical-grade PETG is widely used in oxygen masks, fluid reservoirs, procedural kits, face shields, and diagnostic accessories because of its transparency and impact resistance.

Growth in diagnostic testing infrastructure is particularly relevant. Several Asia-Pacific countries increased healthcare laboratory investments between 2025 and 2026 to strengthen domestic testing capacity. In November 2025, India approved additional funding allocations for medical diagnostics manufacturing under healthcare-linked industrial incentive programs, indirectly supporting domestic polymer demand for laboratory consumables and medical packaging.

Diagnostic consumables production growth is outpacing several traditional medical plastics segments. Laboratory consumables demand is projected to increase by more than 7% in 2026, creating stronger procurement volumes for PETG sheets and injection molding grades.

Sustainability Requirements Are Reshaping Material Procurement

Environmental compliance considerations are becoming increasingly influential in healthcare material selection. While medical applications still prioritize sterility and regulatory reliability, procurement teams are placing greater emphasis on recyclable polymer streams and lifecycle documentation.

This transition is supporting demand for copolyester-based materials with improved recyclability profiles compared with mixed-material packaging structures. Resin suppliers are now introducing healthcare-compatible grades containing mechanically recycled content for non-invasive packaging applications.

In April 2026, Eastman Chemical Company introduced additional molecular recycling supply agreements targeting specialty polyester applications, including healthcare packaging segments requiring traceability-certified recycled inputs.

European healthcare systems are particularly active in sustainable procurement implementation. Public hospital purchasing frameworks in several EU countries now include packaging waste reduction scoring systems during supplier evaluations. As a result, converters using recyclable transparent polymers are improving competitive positioning during long-term healthcare tenders.

However, sustainability transitions remain uneven across product categories. High-risk implantable and critical-contact applications still prioritize virgin medical-grade polymers due to strict regulatory validation requirements.

Medical Device Outsourcing Is Increasing Material Consumption Across Asia-Pacific

Contract manufacturing growth across Asia-Pacific is materially affecting regional PETG demand patterns. Medical device OEMs are increasingly outsourcing assembly and packaging operations to manufacturing hubs in China, Malaysia, Vietnam, and India to manage production costs and supply flexibility.

This shift is increasing regional consumption of thermoforming sheets, injection-molding compounds, and transparent medical housings. Asia-Pacific now accounts for more than two-fifths of global medical PETG consumption, supported by expanding converter capacity and lower processing costs.

In August 2025, Gerresheimer AG announced capacity expansion initiatives in Asia for medical and pharmaceutical packaging production. Similar investments from multinational packaging companies are increasing localized demand for regulated medical polymers.

Supply chain regionalization has also intensified after healthcare manufacturers experienced logistics disruptions in earlier years. Pharmaceutical packaging buyers increasingly prefer geographically diversified polymer sourcing arrangements to reduce procurement risk.

Sterilization Compatibility Is Supporting Material Preference

Sterilization performance remains one of the most important technical selection criteria in medical polymer purchasing. PETG materials are gaining preference in applications requiring compatibility with ethylene oxide and gamma sterilization systems while maintaining optical clarity.

Material suppliers are investing in low-yellowing formulations because discoloration after sterilization remains a purchasing concern for hospitals and diagnostic manufacturers. Recent procurement specifications increasingly require documented resistance to haze formation and crack propagation after repeated sterilization exposure.

This technical positioning is helping PETG compete more effectively against polyvinyl chloride and selected styrenic materials in transparent healthcare applications. Demand is particularly strong in diagnostic cartridges, protective barriers, and equipment housings where visual monitoring is operationally important.

The broader medical device industry is also supporting long-term polymer demand. In February 2026, Advanced Medical Technology Association indicated continued investment momentum in minimally invasive and diagnostic device manufacturing, categories that frequently utilize transparent engineered polymers for disposable and semi-durable components.

Pricing Pressure and Feedstock Volatility Remain Structural Challenges

Despite positive demand indicators, the Medical-Grade Polyethylene Terephthalate Glycol (PETG) Market continues to face pressure from feedstock volatility and healthcare cost-control policies. Copolyester resin pricing remains sensitive to fluctuations in purified terephthalic acid and specialty glycol supply conditions.

Medical converters are increasingly negotiating long-duration procurement contracts to stabilize material costs. Smaller manufacturers remain vulnerable to margin pressure because regulatory-grade polymers require stringent validation, limiting rapid supplier substitution.

Competition from alternative medical plastics also remains significant. Polycarbonate, cyclic olefin copolymers, and specialty polypropylene compounds continue competing in high-performance medical applications where heat resistance or advanced chemical compatibility requirements exceed PETG performance capabilities.

Nevertheless, transparent healthcare packaging, diagnostic consumables, and disposable medical systems are expected to maintain steady consumption growth through the forecast period, supporting continued expansion opportunities for specialized medical-grade copolyester producers.

Regional Demand Patterns in the Medical-Grade Polyethylene Terephthalate Glycol (PETG) Market

Geographical demand in the Medical-Grade Polyethylene Terephthalate Glycol (PETG) Market remains concentrated across North America, Europe, and Asia-Pacific, although purchasing behavior and application priorities differ substantially between regions. Asia-Pacific leads total consumption volume in 2026, while North America continues to dominate higher-value specialty medical formulations used in regulated pharmaceutical and diagnostic environments.

Asia-Pacific Expands Manufacturing and Consumption Base

Asia-Pacific accounts for nearly 41% of global demand for medical-grade PETG materials in 2026, supported by rapid expansion in medical device assembly, pharmaceutical packaging conversion, and laboratory consumables manufacturing. China remains the largest regional consumer, followed by Japan, India, and South Korea.

Medical packaging production growth across China has accelerated due to increased domestic pharmaceutical output and expansion of export-oriented device manufacturing. Transparent rigid packaging applications have gained momentum because of higher adoption of sterile barrier systems in hospital procurement programs.

In December 2025, China National Medical Products Administration introduced additional inspection requirements for sterile medical packaging traceability, increasing demand for validated medical polymer grades with improved documentation and compliance support.

India is emerging as a fast-growing regional market due to government-backed healthcare manufacturing initiatives. Expansion of domestic diagnostic production capacity and hospital infrastructure spending are increasing procurement of PETG sheets and molded medical components. Medical consumables manufacturing investments in India rose by more than 9% between 2025 and 2026, supporting higher demand for transparent copolyester materials used in procedural kits and laboratory products.

Japan and South Korea continue focusing on higher-specification medical polymer applications, including diagnostic cartridges, surgical housings, and precision laboratory equipment. Demand in these countries is driven more by performance consistency and sterilization resistance than by low-cost production advantages.

North America Maintains Strong Position in High-Value Medical Applications

North America represents approximately 29% of global market revenue in 2026, supported by advanced healthcare infrastructure and high utilization of disposable medical technologies. The United States remains the region’s largest consumer due to sustained investment in diagnostic systems, biopharmaceutical production, and surgical device manufacturing.

Healthcare packaging demand remains particularly strong in the United States because pharmaceutical companies increasingly require transparent and recyclable rigid packaging formats. Sterile packaging suppliers are also transitioning toward BPA-free copolyester solutions to align with hospital sustainability policies and procurement specifications.

In March 2026, U.S. Department of Health and Human Services announced expanded funding allocations for domestic medical supply chain resilience programs, indirectly supporting demand for healthcare packaging materials and medical polymer conversion capacity.

Mexico is becoming increasingly important as a regional medical manufacturing hub. Growth in export-oriented device assembly facilities is driving higher consumption of thermoformed PETG trays and transparent medical housings used in cross-border healthcare supply chains.

Canada continues to see moderate but stable growth in pharmaceutical packaging demand, particularly for laboratory diagnostics and specialty biologics handling systems.

Europe Focuses on Sustainability and Regulatory Compliance

European demand patterns are heavily shaped by environmental regulation and healthcare procurement policies. Germany, France, Italy, and the United Kingdom remain the largest consumers of medical-grade PETG materials across the region.

The European healthcare sector is increasingly integrating recyclable-material requirements into public procurement systems. This is supporting adoption of copolyester materials capable of mechanical or molecular recycling within controlled medical packaging streams.

In February 2026, European Medicines Agency expanded discussions around packaging sustainability and traceability documentation for pharmaceutical supply chains, encouraging packaging manufacturers to strengthen material disclosure practices.

Germany remains Europe’s largest medical device manufacturing base and continues to generate substantial demand for sterilizable transparent polymers. Demand from surgical instrumentation packaging and diagnostic device production has remained stable despite broader industrial slowdown concerns across segments of the European chemical industry.

The United Kingdom is witnessing increased utilization of PETG in laboratory automation systems and diagnostic consumables. Demand is supported by expansion of molecular diagnostics and outpatient testing infrastructure.

Latin America and Middle East Show Selective Growth

Latin America remains a comparatively smaller market but is demonstrating gradual growth in healthcare packaging and hospital consumables demand. Brazil accounts for the majority of regional consumption due to its pharmaceutical manufacturing capacity and expanding private healthcare infrastructure.

Middle Eastern demand is concentrated in Gulf Cooperation Council countries, where healthcare modernization projects are increasing imports of medical devices and sterile packaging products. Saudi Arabia and the United Arab Emirates are investing in localized healthcare manufacturing, although domestic polymer conversion capacity remains limited compared with Asia-Pacific.

Medical-Grade Polyethylene Terephthalate Glycol (PETG) Market Segmentation Highlights

By Application

• Healthcare and pharmaceutical packaging holds approximately 36% market share in 2026
• Thermoformed surgical trays account for nearly 28% of total application demand
• Diagnostic consumables segment projected to grow at 7.8% annually through 2031
• Respiratory and fluid management components continue showing stable procurement growth
• Protective barriers and medical face shields maintain moderate post-pandemic replacement demand

By End User

• Medical device manufacturers remain the largest buyers of medical-grade PETG materials
• Pharmaceutical packaging converters represent the second-largest demand segment
• Contract manufacturing organizations are increasing purchasing volumes across Asia-Pacific
• Laboratory equipment manufacturers continue adopting PETG for transparent diagnostic housings

By Processing Technology

• Thermoforming dominates total material consumption volume
• Injection molding applications are expanding in diagnostic and laboratory products
• Extruded sheet applications continue gaining share in sterile packaging systems
• Additive manufacturing usage remains limited but is gradually expanding in prototyping applications

Medical-Grade Polyethylene Terephthalate Glycol (PETG) Production Landscape

Global Medical-Grade Polyethylene Terephthalate Glycol (PETG) production capacity is becoming increasingly concentrated among specialty copolyester manufacturers with healthcare-grade regulatory expertise. The United States, South Korea, China, and parts of Western Europe remain the primary production centers for regulated medical formulations.

Total global Medical-Grade Polyethylene Terephthalate Glycol (PETG) production is estimated to exceed 920 kilotons in 2026, with Asia-Pacific contributing nearly 46% of overall output. Expansion activity is strongest in China and South Korea, where resin producers are increasing specialty polymer lines dedicated to healthcare and diagnostic applications.

In September 2025, SK Chemicals expanded copolyester production infrastructure for high-transparency specialty applications, including medical and healthcare packaging grades. Similar investments are being observed among regional converters seeking localized resin sourcing.

North American Medical-Grade Polyethylene Terephthalate Glycol (PETG) production continues emphasizing high-purity formulations and validated compliance documentation rather than large-scale commodity output. Producers in the United States are increasingly investing in recycling-compatible copolyester technologies to align with healthcare sustainability targets.

Medical-Grade Polyethylene Terephthalate Glycol (PETG) Price Dynamics

The Medical-Grade Polyethylene Terephthalate Glycol (PETG) Price environment in 2026 remains moderately volatile due to fluctuations in purified terephthalic acid, specialty glycol feedstocks, logistics costs, and energy pricing.

Average global Medical-Grade Polyethylene Terephthalate Glycol (PETG) Price levels increased by approximately 4.8% between mid-2025 and early 2026 following tighter specialty chemical supply conditions in Asia and elevated freight expenses for regulated healthcare polymers.

North American medical-grade PETG prices remain higher than Asian averages because of stricter validation requirements and specialized production standards. European buyers are additionally facing increased compliance-related packaging costs tied to sustainability certification and recycled-material traceability requirements.

Medical-Grade Polyethylene Terephthalate Glycol (PETG) Price Trend Across Regions

The global Medical-Grade Polyethylene Terephthalate Glycol (PETG) Price Trend during 2025–2026 reflects divergent regional supply conditions rather than uniform market tightening.

• Asia-Pacific prices stabilized during early 2026 after new specialty polymer capacities entered commercial production
• European contract pricing remained elevated because of energy and regulatory compliance costs
• North American spot prices increased due to higher demand from pharmaceutical packaging converters
• Freight normalization reduced some import pressure for buyers in Latin America and the Middle East

The Medical-Grade Polyethylene Terephthalate Glycol (PETG) Price Trend is also being affected by sustainability-linked procurement standards. Recyclable and traceability-certified medical PETG grades currently command pricing premiums ranging from 8% to 15% compared with conventional formulations.

Market participants increasingly expect long-term procurement agreements to become more common as healthcare manufacturers attempt to reduce exposure to feedstock and logistics volatility. However, pricing pressure is likely to remain sensitive to raw material supply disruptions and changes in pharmaceutical packaging regulations through the forecast period.

Leading Manufacturers in the Medical-Grade Polyethylene Terephthalate Glycol (PETG) Market

The competitive environment in the Medical-Grade Polyethylene Terephthalate Glycol (PETG) Market remains concentrated among a limited number of specialty polymer manufacturers with established healthcare-grade production capabilities. Regulatory validation requirements, sterilization compatibility standards, and long-term supply reliability continue to create high barriers for new entrants. As a result, multinational producers with advanced copolyester technologies maintain a strong hold over premium medical applications.

Competition is increasingly shifting beyond conventional resin supply toward sustainable healthcare packaging, recyclable copolyester development, and low-extractable medical formulations. Manufacturers capable of offering transparent polymers with consistent biocompatibility and sterilization resistance are securing stronger positions in pharmaceutical packaging and diagnostic device applications.

Eastman Chemical Company

Eastman remains one of the largest participants in the Medical-Grade Polyethylene Terephthalate Glycol (PETG) Market, supported by its broad portfolio of healthcare-focused copolyesters. The company’s Eastar, Tritan, Spectar, and Cadence product families are widely used in sterile medical packaging, respiratory devices, laboratory consumables, and diagnostic equipment housings.

Eastar 6763 continues to be one of the most commonly utilized PETG grades in thermoformed medical trays and pharmaceutical packaging because of its optical clarity and sterilization compatibility. Eastman has also expanded focus on recycled-content healthcare packaging materials through its Renew product line, targeting hospitals and pharmaceutical companies seeking sustainability-linked procurement compliance.

North America remains Eastman’s strongest market, although the company continues expanding supply relationships across Europe and Asia-Pacific. Its established regulatory acceptance within pharmaceutical packaging systems provides a major competitive advantage, particularly for long-cycle medical qualification programs.

SK Chemicals

SK Chemicals has strengthened its position in transparent medical copolyesters through aggressive investment in recyclable and high-function PETG materials. The company’s ECOTRIA, ECOZEN, and SKYPET product lines are increasingly used in healthcare packaging, diagnostic consumables, and transparent medical housings.

The company benefits from strong production infrastructure in South Korea and increasing penetration into Asia-Pacific medical packaging supply chains. Its recyclable copolyester technologies are gaining attention among healthcare manufacturers seeking alternatives to polycarbonate and PVC materials.

SK Chemicals is also focusing heavily on circular recycling systems and sustainable polymer technologies. This positioning is becoming increasingly important as European and North American healthcare procurement systems adopt recyclable-material requirements in supplier evaluations.

Pacur LLC

Pacur maintains a significant role in medical PETG sheet extrusion and thermoforming applications. The company specializes in high-clarity PETG sheets used for surgical trays, sterile barrier systems, procedure kits, and clamshell packaging.

Its close integration with healthcare packaging converters allows the company to maintain stable demand from hospitals and medical device manufacturers. Pacur’s product positioning is particularly strong in North America, where demand for transparent thermoformed medical packaging remains high.

The company has also increased development activity around sustainable packaging structures using recyclable copolyester materials for healthcare applications.

Tekni-Plex

Tekni-Plex remains a major participant in sterile healthcare packaging systems utilizing medical-grade PETG materials. The company supplies rigid packaging formats for pharmaceutical products, diagnostic systems, and surgical devices.

The company’s packaging division continues benefiting from growth in single-use medical products and biologics packaging. Tekni-Plex is also increasing investments in mono-material recyclable packaging structures to align with changing environmental regulations across Europe and North America.

Demand for transparent rigid packaging in pharmaceutical logistics and diagnostic transportation systems continues supporting the company’s PETG-related healthcare packaging business.

Gerresheimer AG

Gerresheimer continues expanding its healthcare packaging operations across pharmaceutical and medical applications. The company utilizes medical-grade PETG materials in pharmaceutical containment systems, laboratory packaging, and transparent diagnostic product components.

Its strong relationships with pharmaceutical manufacturers and healthcare packaging buyers support long-term procurement stability. Expansion of production operations in Asia has also increased the company’s exposure to fast-growing regional healthcare packaging demand.

Other Regional and Specialty Producers

Several regional manufacturers across China, Europe, and Southeast Asia are gradually expanding participation in the Medical-Grade Polyethylene Terephthalate Glycol (PETG) Market. However, most smaller suppliers remain concentrated in lower-risk packaging and sheet extrusion applications rather than high-regulation medical device categories.

Chinese manufacturers are increasing specialty copolyester production capacity to reduce dependence on imported healthcare polymers. Nevertheless, multinational companies still dominate premium medical applications because global pharmaceutical and diagnostic companies prioritize validated suppliers with long compliance histories.

Japanese specialty polymer producers continue focusing on precision healthcare applications requiring high optical clarity and dimensional stability. European converters are also developing customized PETG structures for sustainable pharmaceutical packaging systems.

Medical-Grade Polyethylene Terephthalate Glycol (PETG) Market Share by Manufacturers

The Medical-Grade Polyethylene Terephthalate Glycol (PETG) Market share by manufacturers remains heavily influenced by healthcare packaging relationships, regulatory certifications, and production scalability.

Eastman Chemical Company holds the leading global position, accounting for roughly one-third of worldwide medical-grade PETG revenue in 2026. Its dominance is supported by broad healthcare product acceptance and advanced copolyester processing technologies.

SK Chemicals represents the second-largest manufacturer group, with particularly strong growth momentum across Asia-Pacific. The company is steadily increasing market penetration through sustainable PETG technologies and transparent specialty polymers designed for medical and packaging applications.

Pacur and Tekni-Plex maintain important shares within thermoformed medical packaging and sterile barrier systems. Their integration with healthcare packaging conversion operations strengthens their competitive position despite lower overall resin production volumes compared with global chemical manufacturers.

Gerresheimer’s market participation is more concentrated in downstream pharmaceutical packaging systems rather than upstream resin manufacturing, although its role in healthcare packaging demand remains influential.

Regional suppliers collectively account for nearly one-quarter of total market activity, especially in localized sheet extrusion, packaging conversion, and lower-specification healthcare applications.

Competitive Trends Reshaping the Market

Manufacturers in the Medical-Grade Polyethylene Terephthalate Glycol (PETG) Market are increasingly competing on sustainability performance, sterilization stability, and traceability support rather than solely on pricing.

Healthcare packaging buyers now prioritize:

• Recyclable copolyester structures
• BPA-free medical polymers
• Low-extractable material formulations
• Sterilization-resistant transparency
• Regulatory documentation support
• Stable long-term supply agreements

This transition is favoring large multinational suppliers capable of investing in recycling technologies, specialty healthcare testing, and compliance infrastructure.

Producers are also increasing investments in gamma-stable PETG grades for diagnostic systems and laboratory consumables. Demand for transparent medical materials with improved chemical resistance is expanding as molecular diagnostics and biologics handling applications continue growing.

Recent Industry Developments and Market Activity

In April 2026, Eastman announced additional pricing adjustments for specialty PETG materials across Asia and Europe due to increased feedstock and logistics costs affecting healthcare-grade polymers.

In February 2026, Eastman accelerated commercialization plans for recycled-content copolyesters used in medical thermoforming applications as healthcare packaging buyers increased sustainability procurement requirements.

In late 2025, SK Chemicals expanded strategic investment in recyclable specialty copolyesters for healthcare and transparent packaging applications, strengthening its global medical materials portfolio.

During 2025 and 2026, multiple healthcare packaging converters across Europe increased adoption of recyclable PETG-based thermoforming structures to comply with evolving hospital sustainability procurement frameworks.

Gerresheimer continued expanding pharmaceutical packaging capacity in Asia-Pacific during 2025 to support rising regional healthcare manufacturing demand, indirectly increasing consumption of regulated transparent copolyester materials.

Tekni-Plex also increased focus on mono-material healthcare packaging systems during 2026 as pharmaceutical companies sought improved recyclability and simplified material recovery solutions for rigid medical packaging formats.